Advances in Renal Diseases and Dialysis | Book Publisher International

 This book primarily covers key areas of kidney diseases and recent developments in dialysis. The contributions by the authors include acute kidney injury, chronic kidney disease, newer biomarkers of AKI, epidemiology, hepatorenal syndrome, cirrhosis, liver transplantation, acute tubular necrosis, vasopressors, newer biomarkers of HRS, diabetic kidney disease, microvascular damage, microalbuminuria, progression of CKD, RAS mechanism of action, continuous renal replacement therapy, intermittent hemodialysis, hemofiltration, hemodiafiltration, solute removal, electrolyte disorders, uremia, hyperammonemia, diffusion. This book contains various materials suitable for students, researchers and academicians in the field of medicine and medical research.

Author(s) Details:

Maheshwari Kata,
Department of Internal Medicine, MNR Medical College and Hospital, Telangana, India.

Harkesh Arora,
Department of Internal Medicine, Lovelace Medical Center, Albuquerque, New Mexico, USA.

Rajeshwari Ramachandran,
Department of Gastroenterology, Brooklyn Hospital Center, Brooklyn, New York, USA.

Varun Victor,
Department of Cardiology, Canton Medical Education Foundation/Aultman Hospital, Canton, Ohio, USA.

Nihar Jena,
Department of Cardiology, Trinity Health Oakland/Wayne State University, Pontiac, Michigan, USA.

Abid Rizvi,
Department of Behavioural Health and Psychiatry, West Virginia University, Morgantown, West Virginia, USA.

Prashanth Reddy Yella,
Department of Internal Medicine, Yuma Regional Medical Center, Yuma, Arizona, USA.

Atul Bali,
Department of Internal Medicine/Nephrology, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, USA.

Deepak Chandramohan,
Department of Internal Medicine/Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Roopa Naik,
Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, USA.

Please see the link here: https://stm.bookpi.org/ARDD/article/view/11830

Pediatric Liver Transplantation: A Clinical Review | Chapter 16 | Recent Developments in Medicine and Medical Research Vol. 3

 End-stage liver disease and fulminant hepatic failure are both treated with liver transplantation. Patients with End-Stage Liver Disease have seen a considerable improvement in their prognosis. The juvenile liver transplantation and its related therapies are described in this clinical evaluation. Donating a living organ is a difficult decision for the donor and his or her family. A good donor is mentally, physically, and psychologically well. The goal of donor evaluation is to determine whether or not a donor is suitable for donation and to uncover any concealed medical conditions in him or her. It gives the child and family a ray of hope and the chance to live a long and healthy life.

Author (S) Details

J. S. Simi Mohan

Department of Pediatrics, Dr. Somervell Memorial CSI Medical College, India.

View Book :- https://stm.bookpi.org/RDMMR-V3/article/view/4163

Rate of Death in Fatal Diseases and Lymphocyte Reproductive Activity Normalized to Numbers of Hematopoietic Stem Cells in Blood | Chapter 3 | New Visions in Biological Science Vol. 1

 The goal of this study was to see how distinct reductions in lymphocytopoietic state affect the viability of patients with malignant and non-malignant pathologies, with the expectation of similar outcomes based on widely recognised immune defence theory. The changes in death rates in the adult population between the ages of + (55-62) years are opposite for malignant and non-malignant diseases, indicating a lack of protumor activity as well as the common morphogenic activity of lymphopoiesis due to its physiological weakening rather than the widely held belief that enhancing antitumor immunity is the cause. Flow cytometry was used to investigate the numbers of CD133+ and CD31+ lymphocytes, as well as those in the G2-M phases, in the total fraction of circulating lymphocytes from patients with fatal liver cirrhosis and advanced lung cancer over a long period of conventional treatment with OLT or palliative surgery followed by myelosuppressive chemotherapy. The link between specific reproductive activity, or sRA (G2-M/CD133+), and the number of committed liver a-fetoprotein-positive (AFP+) cells, as measured by exponential approximation survival curves for both diseases, was studied. Patients with abnormal sRA after OLT and LC patients with excessive sRA above a healthy level had greater death rates and shorter survival times, which coincided with significant immunosuppression produced by anti-rejection and anti-cancer therapy. Rather than cellular immunity, these findings could be explained by the morphogenesis (feeding) activity of circulating lymphocytes directed at both normal and malignant tissues. The variations in sRA could be a useful biomarker for tracking engraftment or tumour growth.

Author (S) Details

Aleksei N. Shoutko
Granov’s Federal Research Center for Radiology and Surgical Technologies, Fundamental Research Department of Saint-Petersburg, Russia.

Olga A. Gerasimova
Granov’s Federal Research Center for Radiology and Surgical Technologies, Outpatient Center for Transplantation, Hepatology, and Nephrology, Saint-Petersburg, Russia.

Viktor F. Mus
Granov’s Federal Research Center for Radiology and Surgical Technologies, Group for Lung Cancer Treatment, Saint-Petersburg, Russia.

View Book :- https://stm.bookpi.org/NVBS-V1/article/view/3171

Liver Transplantation Studies Using a Canine Model: A Zoom on the Intermediate Filaments of the Cytoskeleton of the Hepatocytes | Chapter 3 | Highlights on Medicine and Medical Research Vol. 9

 Liver transplantation can be used to treat both acute and chronic liver insufficiency. Graft malfunction persists in the twenty-first century. It affects up to one-third of those who receive it, despite reports of good to exceptional long-term outcomes. The etiologic examination of organ dysfunction revealed a complex basis at the time of authoring this chapter. Ischemia and reperfusion (I/R) injury is arguably the most major contributing factor for organ dysfunction, despite the numerous etiology. Cholestasis, or the cessation or reduction of bile flow with or without bile, is a condition in which the flow of bile is stopped or reduced. I/R damage is frequently accompanied with duct loss or ductopenia, as well as biliary ductular proliferations. They can, however, be deceiving, as they can also be present in other types of graft malfunction. Biliary marker levels often rise within 5 days of donation. The intermediate filaments of the cytoskeleton were studied in detail in this chapter using a liver transplantation model as an I/R damage model. The phenotypic flip of hepatocytes occurs before frank cholestasis, according to our findings. We believe that focusing on this phenotypic transformation in liver cells could aid in the savage or improved fate of the liver transplantation.

Author (s) Details

Consolato M. Sergi
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada and Stollery Children’s Hospital, University Alberta Hospital, Edmonton, AB, Canada.

View Book :- https://stm.bookpi.org/HMMR-V9/article/view/1023